LAPS-Exendin

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for LAPS-Exendin, covering 2014-02-11 to 2016-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus [Phase 2]

See pricing